Combination Chemotherapy and Interferon Alfa-2b in Treating Patients With Nonmetastatic Liver Cancer That Cannot Be Removed by Surgery
Condition(s):Liver CancerLast Updated:June 22, 2011Unknown status
Hide Studies Not Open or Pending
Condition(s):Liver CancerLast Updated:June 22, 2011Unknown status
Condition(s):Liver CancerLast Updated:November 8, 2017Completed
Condition(s):Hepatocellular Carcinoma ResectableLast Updated:March 13, 2023Recruiting
Condition(s):Liver, Cancer of, Primary ResectableLast Updated:March 2, 2023Recruiting
Condition(s):Colorectal Cancer; Islet Cell Tumor; Liver Cancer; Metastatic Cancer; Neuroendocrine CarcinomaLast Updated:March 23, 2012Completed
Condition(s):Circulating Neoplastic Cells; Adverse Effect of Radiation Therapy; Fatal OutcomeLast Updated:February 5, 2015Unknown status
Condition(s):NASH – Nonalcoholic SteatohepatitisLast Updated:November 24, 2023Active, not recruiting
Condition(s):Liver CancerLast Updated:July 27, 2018Unknown status
Condition(s):Efficacy and SafetyLast Updated:August 21, 2017Unknown status
Condition(s):Liver Neoplasms; Hepatocellular Carcinoma; Liver MetastasesLast Updated:January 29, 2024Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.